Showing 1 - 4 results of 4 for search '"MIR497HG"', query time: 0.56s Refine Results
  1. 1
    Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling

    Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling by Changshui Zhuang, Ying Liu, Shengqiang Fu, Chaobo Yuan, Jingwen Luo, Xueting Huang, Weifeng Yang, Wuwei Xie, Chengle Zhuang

    Published 2020-12-01
    Subjects:
    Get full text
    Article
  2. 2
    Corrigendum: Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling

    Corrigendum: Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling by Changshui Zhuang, Ying Liu, Shengqiang Fu, Chaobo Yuan, Jingwen Luo, Xueting Huang, Weifeng Yang, Wuwei Xie, Chengle Zhuang

    Published 2021-09-01
    Subjects:
    Get full text
    Article
  3. 3
    The mechanism and therapeutic potential of lncRNA MIR497HG/miR-16-5p axis in breast cancer

    The mechanism and therapeutic potential of lncRNA MIR497HG/miR-16-5p axis in breast cancer by Quan Cheng, Dong-Yang Yu, Yong-Hong Zhou, Jian-Yuan Huang

    Published 2024-07-01
    Subjects:
    Get full text
    Article
  4. 4
    MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer

    MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer by Yao Tian, Zhao‐Hui Chen, Peng Wu, Di Zhang, Yue Ma, Xiao‐Feng Liu, Xin Wang, Dan Ding, Xu‐Chen Cao, Yue Yu

    Published 2023-04-01
    Subjects:
    Get full text
    Article

Search Tools: